122 related articles for article (PubMed ID: 1693314)
1. Phase II studies of ifosfamide alone and in combination in cancer of the cervix.
Blackledge G; Buxton EJ; Mould JJ; Monaghan J; Paterson M; Tobias J; Alcock C; Spooner D; Meanwell CA
Cancer Chemother Pharmacol; 1990; 26 Suppl():S12-6. PubMed ID: 1693314
[TBL] [Abstract][Full Text] [Related]
2. The role of ifosfamide in cervical cancer.
Buxton EJ; Blackledge G; Mould JJ; Monaghan J; Paterson M; Tobias J; Alcock C; Spooner D; Meanwell CA
Semin Oncol; 1989 Feb; 16(1 Suppl 3):60-7. PubMed ID: 2468183
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant bleomycin, ifosfamide and cisplatin in cervical cancer.
Tobias J; Buxton EJ; Blackledge G; Mould JJ; Monaghan J; Spooner D; Chetiyawardana A
Cancer Chemother Pharmacol; 1990; 26 Suppl():S59-62. PubMed ID: 1693316
[TBL] [Abstract][Full Text] [Related]
4. Combination bleomycin, ifosfamide, and cisplatin chemotherapy in cervical cancer.
Buxton EJ; Meanwell CA; Hilton C; Mould JJ; Spooner D; Chetiyawardana A; Latief T; Paterson M; Redman CW; Luesley DM
J Natl Cancer Inst; 1989 Mar; 81(5):359-61. PubMed ID: 2464699
[TBL] [Abstract][Full Text] [Related]
5. Phase II studies of bleomycin, ifosfamide and cis-platinum in advanced and recurrent cervical carcinoma.
Buxton EJ; Meanwell CA; Mould JJ; Latief T; Chetiyawardana AD; Spooner D; Tobias JS; Sokal M; Alcock C; Hilton C
Acta Oncol; 1988; 27(5):545-9. PubMed ID: 2462439
[TBL] [Abstract][Full Text] [Related]
6. A randomised, prospective, phase III clinical trial of primary bleomycin, ifosfamide and cisplatin (BIP) chemotherapy followed by radiotherapy versus radiotherapy alone in inoperable cancer of the cervix.
Herod J; Burton A; Buxton J; Tobias J; Luesley D; Jordan S; Dunn J; Poole CJ
Ann Oncol; 2000 Sep; 11(9):1175-81. PubMed ID: 11061615
[TBL] [Abstract][Full Text] [Related]
7. Experience with bleomycin, ifosfamide, and cisplatin in primary and recurrent cervical cancer.
Buxton EJ
Semin Oncol; 1992 Apr; 19(2 Suppl 5):9-17; discussion 17-8. PubMed ID: 1384148
[TBL] [Abstract][Full Text] [Related]
8. Retrospective analysis of concurrent chemoradiation with the combination of bleomycin, ifosfamide and cisplatin (BIP) for uterine cervical cancer.
Aoki M; Akahira J; Niikura H; Saito S; Abe Y; Aida T; Sato N; Kitamura T; Otsuki K; Katahira A; Utsunomiya H; Okamura C; Takano T; Ito K; Okamura K; Yaegashi N
Tohoku J Exp Med; 2004 Dec; 204(4):309-15. PubMed ID: 15572856
[TBL] [Abstract][Full Text] [Related]
9. Single agent versus combination chemotherapy in recurrent cervical cancer.
Kumar L; Pokharel YH; Kumar S; Singh R; Rath GK; Kochupillai V
J Obstet Gynaecol Res; 1998 Dec; 24(6):401-9. PubMed ID: 10063235
[TBL] [Abstract][Full Text] [Related]
10. Bleomycin, cisplatinum and ifosfamide infusion chemotherapy in advanced/recurrent cancer of cervix.
Singhal RM; Jindel R; Gupta AK
Indian J Cancer; 1993 Dec; 30(4):158-63. PubMed ID: 7515843
[TBL] [Abstract][Full Text] [Related]
11. The addition of bleomycin and dose-escalated ifosfamide to the combination of cisplatin plus ifosfamide does not improve survival in advanced or recurrent cervical carcinoma.
Hempling RE; Eltabbakh GH; Piver MS; Recio FO; O'Neill CP
Am J Clin Oncol; 1997 Jun; 20(3):315-8. PubMed ID: 9167762
[TBL] [Abstract][Full Text] [Related]
12. The potential for adjuvant therapy in early-stage cervical cancer.
Buxton EJ; Saunders N; Blackledge GR; Kelly K; Redman CW; Monaghan J; Paterson ME; Luesley DM
Cancer Chemother Pharmacol; 1990; 26 Suppl():S17-21. PubMed ID: 1693315
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy in recurrent and advanced cervical cancer.
Kumar L; Bhargava VL
Gynecol Oncol; 1991 Feb; 40(2):107-11. PubMed ID: 1707022
[TBL] [Abstract][Full Text] [Related]
14. Phase II study of ifosfamide in cervical cancer.
Meanwell CA; Mould JJ; Blackledge G; Lawton FG; Stuart NS; Kavanagh J; Latief TN; Spooner D; Chetiyawardana AD
Cancer Treat Rep; 1986 Jun; 70(6):727-30. PubMed ID: 3089596
[TBL] [Abstract][Full Text] [Related]
15. Combined chemotherapy using cisplatin, ifosfamide and bleomycin (PIB) in the treatment of advanced and recurrent cervical carcinoma.
Tay SK; Lai FM; Soh LT; Ho TH; Ang PT; Au E
Aust N Z J Obstet Gynaecol; 1992 Aug; 32(3):263-6. PubMed ID: 1280100
[TBL] [Abstract][Full Text] [Related]
16. Randomized trial of cisplatin and ifosfamide with or without bleomycin in squamous carcinoma of the cervix: a gynecologic oncology group study.
Bloss JD; Blessing JA; Behrens BC; Mannel RS; Rader JS; Sood AK; Markman M; Benda J
J Clin Oncol; 2002 Apr; 20(7):1832-7. PubMed ID: 11919241
[TBL] [Abstract][Full Text] [Related]
17. [Combination chemotherapy with nedaplatin, bleomycin and ifosfamide for advanced cervical cancer of the uterus--a preliminary study for phase III clinical study].
Noda K; Hirabayashi K; Terashima Y; Ozaki M; Yakushiji M; Hatae M; Kanazawa K
Gan To Kagaku Ryoho; 1997 Aug; 24(10):1285-93. PubMed ID: 9279348
[TBL] [Abstract][Full Text] [Related]
18. The role of ifosfamide and systemic therapy in the management of carcinoma of the cervix.
Thigpen T; Vance R; Khansur T; Malamud F
Semin Oncol; 1996 Jun; 23(3 Suppl 6):56-64. PubMed ID: 8677451
[TBL] [Abstract][Full Text] [Related]
19. Bleomycin-ifosfamide-cis-platinum (BIP) in pelvic recurrence of previously irradiated cervical carcinoma: a second look.
Ramm K; Vergote IB; Kaern J; Tropé CG
Gynecol Oncol; 1992 Aug; 46(2):203-7. PubMed ID: 1379961
[TBL] [Abstract][Full Text] [Related]
20. Concomitant chemobrachyradiotherapy with ifosfamide and cisplatin followed by consolidation chemotherapy for women with locally advanced carcinoma of the uterine cervix--final results of a prospective phase II-study.
Vrdoljak E; Omrcen T; Novaković ZS; Jelavić TB; Prskalo T; Hrepić D; Hamm W
Gynecol Oncol; 2006 Nov; 103(2):494-9. PubMed ID: 16814371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
